Alexander Egbe
Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alexander Egbe as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:38 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06693674 · Effect of Sacubitril-Valsartan on Cardiac Structure and FunctionMayo Clinic · recruiting · Congenital Heart Disease · principal investigator
- N/ANCT06678256 · A Study of Pregnancy Outcomes in Congenital Heart DiseaseMayo Clinic · withdrawn · Congenital Heart Disease · principal investigator
- N/ANCT06566196 · A Study of Hemodynamic Cardiopulmonary Exercise for CHDMayo Clinic · recruiting · Congenital Heart Disease · principal investigator
- Ph3NCT06150560 · A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)Mayo Clinic · recruiting · Coarctation of Aorta, High Blood Pressure · principal investigator
- N/ANCT05849025 · A Study of Invasive Hemodynamic for MACHD RegistryMayo Clinic · recruiting · Healthy, Congenital Heart Disease · principal investigator
- N/ANCT05773300 · Registry for Mayo Clinic Adult Congenital Heart Disease Control PopulationMayo Clinic · active not recruiting · Healthy · principal investigator
- N/ANCT05122962 · Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart DiseasesMayo Clinic · recruiting · Tetralogy of Fallot, Congenital Heart Disease · principal investigator
- N/ANCT03853837 · Ventricular and Pulmonary Vascular Reserve After the Fontan OperationMayo Clinic · completed · Heart Failure, Congenital Heart Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aortaR01HL162830 · NHLBI · MAYO CLINIC ROCHESTER · fiscal years 2023 to 2026 · $652,025 awarded in 2026Grant number is on one of their registry trials
- Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiologyR01HL160761 · NHLBI · MAYO CLINIC ROCHESTER · fiscal years 2022 to 2026 · $570,748 awarded in 2026Grant number is on one of their registry trials
- Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of FallotR01HL158517 · NHLBI · MAYO CLINIC ROCHESTER · fiscal years 2021 to 2025 · $575,323 awarded in 2025Grant number is on one of their registry trials
- Ventricular and Pulmonary Vascular Reserve after the Fontan OperationK23HL141448 · NHLBI · MAYO CLINIC ROCHESTER · fiscal years 2018 to 2021 · $173,275 awarded in 2021Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:38 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction.Eur Heart J · 2019217 citationsRCR 9.7
- The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction.Circ Res · 201973 citationsRCR 3.2
- Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease.Int J Cardiol · 202322 citationsRCR 3.0